FilingIndex
DEF 14AThe Ballot

Aclaris Therapeutics, Inc. files DEF 14A

Filed May 20, 2016 · 10y ago · Accession 0001558370-16-006090

Plain English

Proxy statement — executive pay, board nominees, and shareholder votes.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
ACRS
CIK
1557746
Form type
DEF 14A
Filing date
May 20, 2016
Report date
Jun 29, 2016
Document
acrs-20160629xdef14a.htm
Size
837 KB